Letter to the Editor
Experience with subcutaneous levetiracetam in palliative care patients: prognostic and pharmacological considerations
Experiencia de uso de levetiracetam subcutáneo en pacientes paliativos: consideración pronóstica y farmacológica
Read
702
Timeswas read the article
178
Total PDF
524
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 3 | 0 | 3 |
| 2024 June | 30 | 0 | 30 |
| 2024 May | 24 | 4 | 28 |
| 2024 April | 33 | 8 | 41 |
| 2024 March | 23 | 3 | 26 |
| 2024 February | 20 | 3 | 23 |
| 2024 January | 26 | 4 | 30 |
| 2023 December | 12 | 8 | 20 |
| 2023 November | 17 | 5 | 22 |
| 2023 October | 24 | 14 | 38 |
| 2023 September | 19 | 7 | 26 |
| 2023 August | 16 | 6 | 22 |
| 2023 July | 18 | 5 | 23 |
| 2023 June | 24 | 8 | 32 |
| 2023 May | 52 | 5 | 57 |
| 2023 April | 41 | 4 | 45 |
| 2023 March | 20 | 6 | 26 |
| 2023 February | 16 | 7 | 23 |
| 2023 January | 11 | 12 | 23 |
| 2022 December | 8 | 8 | 16 |
| 2022 November | 19 | 4 | 23 |
| 2022 October | 9 | 5 | 14 |
| 2022 September | 8 | 11 | 19 |
| 2022 August | 22 | 12 | 34 |
| 2022 July | 17 | 8 | 25 |
| 2022 June | 9 | 7 | 16 |
| 2022 May | 3 | 14 | 17 |
Show all
